Sep 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 15 Sep - Sagility to attend 2026 Jefferies India Forum on September 18, 2026 in Gurgaon.
Source: Bse
IT stocks · Small cap · NSE
Sagility Limited (formerly Sagility India Limited) is an IT company providing healthcare operations, clinical services, and AI-led transformation capabilities. It focuses on strengthening its position in healthcare quality, especially for Medicare Advantage plans, through differentiated analytics and HEDIS capabilities.
SMA20 -2.4% / mo · MACD + · sector +14.5pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, while price trend supports entry. This looks more like momentum/speculation than a clean fundamental investment setup.
Weak U-Score but strong trend: momentum may be ahead of fundamentals.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +27.6% · PAT +45.6% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +28% YoY · PAT +46% YoY · operating leverage · margin compression
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹1,963 Cr | +27.6% | -3.0% |
| EBITDA | ₹438 Cr | +26.6% | -9.7% |
| Operating margin | 22.0% | +0 bps | -200 bps |
| PAT | ₹217 Cr | +45.6% | -15.9% |
| PAT margin | 11.1% | +137 bps | -170 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 20/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term uptrend intact. RSI 48. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 39 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +1 points.
Business-comparable peers in IT — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Q1 FY27 saw strong 27.6% YoY revenue growth (15.2% CC) and 35.1% YoY Adjusted PAT growth, driven by existing client expansion and new wins. Adjusted EBITDA margin remained steady at 24.0% YoY, but declined QoQ due to seasonal revenue absence and wage hikes.
Sagility delivered robust Q1 FY27 results with strong organic growth and a strategic acquisition (CareSeed) enhancing its healthcare quality offerings. While margins held YoY, QoQ decline and wage hike impact warrant monitoring. Client concentration remains high, but diversification efforts are visible.
Latest issuer-disclosed distribution across 2 reported categories.
27.3% Y-o-Y organic growth in Q1 FY27, driven by expansion within existing clients and rising contribution from FY26 new client wins.
Acquired CareSeed to strengthen position in healthcare quality, adding analytics and HEDIS capabilities, expanding platform depth and mid-market reach with 26 new clients.
Won $35.3M of steady state ACV in Q1 FY27, driven by expansion opportunities / new SOWs across 18 existing clients and 1 new logo.
Independent research validates healthcare market trends driving demand for Sagility’s AI and domain-led healthcare operations model.
Independent research validates the healthcare market trends driving demand for Sagility’s AI and domain-led healthcare operations model.
Payer expectations are shifting toward strategic partners, valuing understanding of the complete payer ecosystem and commitment to outcomes.
Increases in statutory minimum wages in Karnataka and Telangana, effective May 22 and June 1, 2026, respectively.
Q1 FY27 Forex loss of ₹283M was driven by foreign exchange hedges.
Top 3 clients contribute 60.1% of TTM Jun'26 revenues, indicating high reliance on a few large clients.
Statutory minimum wage hikes in Karnataka and Telangana are estimated to have a ~1.2% margin impact on revenues for FY27.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
YoY comparison is crucial for assessing long-term growth and the impact of strategic initiatives like acquisitions. QoQ is important to understand sequential momentum, the impact of seasonal revenue absence, and the immediate effects of cost pressures like wage hikes.
Q1 FY27 Revenue from Operation (in ₹ M) 19,635, YoY growth 27.6% (15.2% in CC).
Q1 FY27 Adjusted EBITDA % 24.0%.
Q1 FY27 Adjusted PAT % 13.7%.
Q1 FY27 Voluntary attrition rate^ (%) 28.6%.
Debt to be fully repaid in current Financial year (FY27).
Combining CareSeed’s technology with Sagility’s healthcare operations, clinical services, and AI-led transformation capabilities to deliver an end-to-end quality operations continuum.
Strengthens Sagility's position in Quality for Medicare Advantage (MA) - expanding capabilities across HEDIS, CMS Stars, quality reporting, and care-gap orchestration.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Adjusted EBITDA Margin | 24.0% (Q1 FY27) | Sustained margin levels despite wage hikes and seasonal revenue absence. |
| Steady State ACV Wins | $35.3M (Q1 FY27) | Continued strong deal wins from existing clients and new logos to drive future growth. |
| Client Concentration (Top 3) | 60.1% (TTM Jun'26) | Diversification of revenue base and reduction in reliance on top clients. |
| Debt Repayment | ₹5,670M (Closing Debt FY26) | Full repayment of debt in FY27 as planned. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 94th percentile of the scored universe and 89th percentile within IT. No major sub-score weakness stands out.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · IT: 89th pctile, median 69 · Small: 96th pctile, median 66
48 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse